Pharmaceutical Impurities and Derivatives
Product ID
Name
Description
Purity
-
P005095
N-Debenzoylpaclitaxel
Paclitaxel derivative
≥95% -
T1030
N-Des-2-methylpropan-2-ol Docetaxel
N-Des-2-methylpropan-2-ol Docetaxel is an impur...
≥90% -
N344780
N-Nitroso Bumetanide
Bumetanide impurity
≥99% -
N344784
N-Nitroso Valsartan
Valsartan impurity
≥98% -
N344786
N-Nitroso Valsartan Methyl Ester
Valsartan impurity
-
O486188
Omeprazole Impurity F and G mixture
Regioisomers
≥98% -
C002045
Oxazolidine Cabazitaxel
Synthesis impurity
≥95% -
T1004
Paclitaxel Oxetane Ring-Opened 3-Acetyl 4-Benzoyl Impurity
Synthesis impurity
≥92% -
T1028
Paclitaxel, 8-Hydro-bicyclo(3.3.0)octane
Synthesis impurity
≥95% -
P698574
Prolylrapamycin
Rapamycin analog
-
T1016
Propyl Analog of Paclitaxel
Fermentation impurity
≥95% -
R2788
RGW-611
Morpholine derivative.
≥98% -
R3312
Ridaifen A Dihydrochloride
Tamoxifen derivative; potential proteasome inhi...
≥98% -
S164098
Seco-rapamycin
Rapamycin analog
≥73% -
T0105
Taxol C
Taxane synthesis intermediate.
≥95% -
T1655
Tenoxicam Impurity 1
Tenoxicam impurity
≥98% -
T1656
Tenoxicam Impurity B
Tenoxicam impurity
≥98% -
V014463
Valsartan Methyl Ester
Valsartan impurity
≥98%
Showing 51–72 of 72 results